Zymeworks SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 23, 2026, 6:07 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedZymeworks Inc. Licenses ZW209 to Roche for $55.0 Million Upfront, $40.0 Million Phase Ib Payment and Up to $718 Million in Milestones
4Oct. 9, 2026, 6:28 p.m. ETView on SEC.gov
8-KSept. 23, 2026, 4:06 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Completion of acquisition or disposition of assets · Creation of a direct financial obligation · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 25, 2026, 10:54 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
10-QAug. 6, 2026, 4:11 p.m. ETView on SEC.gov
8-KAug. 6, 2026, 4:09 p.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits